RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition. | RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition. Park J, Nam DH, Kim D, Chung YJ., Free PMC Article | 06/20/2024 |
Autophagy-dependent alternative splicing of ribosomal protein S24 produces a more stable isoform that aids in hypoxic cell survival. | Autophagy-dependent alternative splicing of ribosomal protein S24 produces a more stable isoform that aids in hypoxic cell survival. Kerry J, Specker EJ, Mizzoni M, Brumwell A, Fell L, Goodbrand J, Rosen MN, Uniacke J. | 03/19/2024 |
Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis. | Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis. Wang S, Xia L, Zhang B, Zhang H, Lan F. | 08/13/2022 |
RPS24c Isoform Facilitates Tumor Angiogenesis Via Promoting the Stability of MVIH in Colorectal Cancer. | RPS24c Isoform Facilitates Tumor Angiogenesis Via Promoting the Stability of MVIH in Colorectal Cancer. Wang Y, Wu Y, Xiao K, Zhao Y, Lv G, Xu S, Wu F. | 06/12/2021 |
Three functional variants were identified to affect RPS24 expression and significantly associated with risk of colorectal cancer. | Three functional variants were identified to affect RPS24 expression and significantly associated with risk of colorectal cancer. Zou D, Zhang H, Ke J, Li J, Zhu Y, Gong Y, Yang Y, Tian J, Zhang Y, Peng X, Cai K, Zhong R, Chang J, Miao X. | 02/20/2021 |
The results show that RPS19, RPS21 or RPS24 are upregulated in malignant tissue and may serve as putative biomarkers for prostate cancer. | Expression of ribosomal proteins in normal and cancerous human prostate tissue. Arthurs C, Murtaza BN, Thomson C, Dickens K, Henrique R, Patel HRH, Beltran M, Millar M, Thrasivoulou C, Ahmed A., Free PMC Article | 10/21/2017 |
findings suggest that two rare heterozygous truncating variations (RPS24 Q191X and CD300LF P261fsX266) are risk candidates for autism spectrum disorder. | Rare heterozygous truncating variations and risk of autism spectrum disorder: Whole-exome sequencing of a multiplex family and follow-up study in a Japanese population. Inoue E, Watanabe Y, Egawa J, Sugimoto A, Nunokawa A, Shibuya M, Igeta H, Someya T. | 04/30/2016 |
RPS24 gene may be a promising biomarker for therapy in human colon cancer and may have a potential application in the diagnosis or treatment of human colon cancer. | RPS24 knockdown inhibits colorectal cancer cell migration and proliferation in vitro. Wang Y, Sui J, Li X, Cao F, He J, Yang B, Zhu X, Sun Y, Pu YD. | 12/12/2015 |
Observational study of gene-disease association. (HuGE Navigator) | See all PubMed (2) articlesMutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia. Konno Y, Toki T, Tandai S, Xu G, Wang R, Terui K, Ohga S, Hara T, Hama A, Kojima S, Hasegawa D, Kosaka Y, Yanagisawa R, Koike K, Kanai R, Imai T, Hongo T, Park MJ, Sugita K, Ito E. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations. Quarello P, Garelli E, Carando A, Brusco A, Calabrese R, Dufour C, Longoni D, Misuraca A, Vinti L, Aspesi A, Biondini L, Loreni F, Dianzani I, Ramenghi U. | 12/2/2009 |
Primary fibroblasts from Diamond-Blackfan anemia patients with truncating mutations in RPS19 or in RPS24 have a marked reduction in proliferative capacity. | Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia. Badhai J, Fröjmark AS, J Davey E, Schuster J, Dahl N., Free PMC Article | 01/21/2010 |
Cells from Diamond-Blackfan anemia patients carrying mutations in RPS24 have defective pre-rRNA maturation, as in the case of RPS19 mutations. | Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Choesmel V, Fribourg S, Aguissa-Touré AH, Pinaud N, Legrand P, Gazda HT, Gleizes PE. | 01/21/2010 |